10.3390/cells14050376
Chapters: 00:00 Welcome Back & Super Bowl Banter 05:50 What This Episode Covers: Growth Hormone Secretagogues 06:45 GHRH vs GHRP Explained (Simple Breakdown) 12:50 Tesamorelin: Benefits, Fat Loss & Why Its Top Tier 15:30 CJC-1295 (With vs Without DAC) 19:20 Age, Teens & Secretagogues (Who Should Not Use Them) 23:30 MK-677: Hunger, Muscle Gain & When It Makes Sense 26:50 Dosing Strategy, Timing & Cutting vs Bulking 29:00 Tesamorelin & Sleep Issues (How to Fix It) 34:30 Secretagogues vs Real HGH (What to Use & When) 38:20 Long-Term Benefits: Recovery, Aging & Fat Loss 41:20 TRT, Estrogen, AIs & Whats Coming Next 44:10 Outro & Final Thoughts We cover: GH Secretagogues 101: GHRH vs GHRP GHRH (Tesamorelin, CJC) tells the pituitary to make GH GHRP (Ipamorelin, MK-677, GHRP6) pushes the pulsing & release Why you need both sides of the equation for max effect Warehouse analogy explained: stock + shipping = full power Ranking the Peptides (Effectiveness vs Side Effects) Tesamorelin: 5/5 effectiveness, 2/5 side effects the king of fat loss & GH synergy Ipamorelin: Cleanest GHRP, low prolactin/cortisol risk CJC-1295 (no DAC): Powerful GH increase, occasional histamine response CJC w/ DAC: Long ester = higher blood levels but more estrogenic sides MK-677: Strongest hunger, fullness, and muscle but water retention & fatigue are real Hexarelin, GHRP6, GHRP2: Strong but outdated due to prolactin & side effects Side Effect Note: CJC rash/histamine reaction
$1.6 billion of debt became $465 million
The surface modification of the liposome with ligands (antibodies or peptides) ensures targeted delivery to dopaminergic neurons, which could improve their targeting capabilities and efficacy and reduce side effects
It acts primarily through gene expression modulation, delivering copper to enzymes and triggering transcription factor cascades rather than saturating one receptor
An isolated, yet intriguing, case study involving ibogaine anecdotally reported decreased lesion size and imaging biomarkers consistent with remyelination in an individual with MS [20]
